Free Trial

Xylem (XYL) Stock Forecast & Price Target

Xylem logo
$143.62 +3.40 (+2.43%)
Closing price 03:59 PM Eastern
Extended Trading
$143.76 +0.14 (+0.10%)
As of 06:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Xylem - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
3
Buy
6

Based on 9 Wall Street analysts who have issued ratings for Xylem in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 9 analysts, 3 have given a hold rating, and 6 have given a buy rating for XYL.

Consensus Price Target

$151.57
5.54% Upside
According to the 9 analysts' twelve-month price targets for Xylem, the average price target is $151.57. The highest price target for XYL is $175.00, while the lowest price target for XYL is $125.00. The average price target represents a forecasted upside of 5.54% from the current price of $143.62.
Get the Latest News and Ratings for XYL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Xylem and its competitors.

Sign Up

XYL Analyst Ratings Over Time

TypeCurrent Forecast
8/22/24 to 8/22/25
1 Month Ago
7/23/24 to 7/23/25
3 Months Ago
5/24/24 to 5/24/25
1 Year Ago
8/23/23 to 8/22/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
6 Buy rating(s)
6 Buy rating(s)
7 Buy rating(s)
11 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$151.57$149.29$146.88$147.54
Forecasted Upside5.54% Upside13.23% Upside18.43% Upside8.95% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

XYL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

XYL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Xylem Stock vs. The Competition

TypeXylemBusiness Services CompaniesS&P 500
Consensus Rating Score
2.67
2.70
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside8.07% Upside115.13% Upside11.95% Upside
News Sentiment Rating
Positive News

See Recent XYL News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/5/2025UBS Group
3 of 5 stars
Damian Karas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$164.00 ➝ $168.00+15.98%
8/1/2025Stifel Nicolaus
4 of 5 stars
Nathan Jones
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$162.00 ➝ $175.00+23.51%
7/14/2025Citigroup
2 of 5 stars
A. Kaplowitz
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$137.00 ➝ $152.00+16.17%
5/30/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Mark Strouse
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$148.00+17.85%
5/15/2025Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. Zolper
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
4/30/2025Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Deane Dray
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$143.00 ➝ $147.00+23.38%
4/30/2025Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Michael Halloran
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$149.00 ➝ $146.00+23.38%
12/12/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. Hewitt
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Peer Perform
11/6/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Giordano
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetHold ➝ Hold$138.00 ➝ $125.00+1.12%
5/31/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$147.00 ➝ $152.00+9.71%
5/29/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Eade
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$146.00 ➝ $165.00+19.75%
5/3/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$110.00 ➝ $135.00-0.73%
3/12/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$150.00+18.88%
11/21/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$104.00 ➝ $120.00+19.74%
10/2/2023Melius
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$122.00+33.46%
8/29/2023Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Graham
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 07:04 PM ET.


Should I Buy Xylem Stock? XYL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, August 20, 2025. Please send any questions or comments about these Xylem pros and cons to contact@marketbeat.com.

Xylem
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Xylem Inc.:

  • The current stock price is around $141.72, which is near its 12-month high of $145.33, indicating strong market performance.
  • Xylem Inc. reported a quarterly earnings per share (EPS) of $1.26, exceeding analyst expectations, which reflects robust financial health and operational efficiency.
  • The company has a solid revenue growth of 6.1% compared to the same quarter last year, showcasing its ability to expand and adapt in a competitive market.
  • With a consensus rating of "Moderate Buy" from analysts, there is a positive outlook on the stock, suggesting potential for future appreciation.
  • Xylem Inc. offers a quarterly dividend of $0.40 per share, providing a yield of 1.1%, which can be attractive for income-focused investors.

Xylem
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Xylem Inc. for these reasons:

  • The stock has a relatively high price-to-earnings (P/E) ratio of 36.81, which may indicate that it is overvalued compared to its earnings.
  • Despite positive growth, the company's PEG ratio of 2.44 suggests that the stock may not be growing fast enough to justify its current price, which could deter value investors.
  • With a debt-to-equity ratio of 0.17, while low, it may indicate that the company is not leveraging debt effectively to fuel growth, which could limit expansion opportunities.
  • Analysts have varying price targets, with some estimates being lower than the current stock price, indicating potential volatility and uncertainty in future performance.
  • The market capitalization of $34.50 billion may limit the company's agility in responding to market changes compared to smaller competitors.

XYL Forecast - Frequently Asked Questions

According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for Xylem is $151.57, with a high forecast of $175.00 and a low forecast of $125.00.

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Xylem in the last year. There are currently 3 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" XYL shares.

According to analysts, Xylem's stock has a predicted upside of 5.54% based on their 12-month stock forecasts.

Xylem has been rated by research analysts at Citigroup, JPMorgan Chase & Co., Stifel Nicolaus, and UBS Group in the past 90 days.

Analysts like Xylem less than other "business services" companies. The consensus rating score for Xylem is 2.67 while the average consensus rating score for "business services" companies is 2.70. Learn more on how XYL compares to other companies.


This page (NYSE:XYL) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners